Mensifem (Dry Extract From Cimicifuga Racemosa (L.) Nutt., Rhizoma (Black Cohosh) (5-10:1), Extraction Solvent)

The exact mechanism is not fully understood, but the black cohosh extract is thought to influence serotonergic pathways and exhibit weak estrogen‑like activity in the hypothalamus. This modulation can help stabilize the body’s temperature regulation, reducing the frequency and intensity of hot flashes.

The appropriate dose of Mensifem is determined by the prescribing healthcare professional based on individual patient needs, product formulation and local regulatory guidance. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of black cohosh extracts, including Mensifem, has not been established in pregnancy, and use is generally discouraged. Limited data exist for breastfeeding; therefore, caution is advised and the product should only be used if the benefits outweigh potential risks, under medical supervision.

To request Mensifem, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mensifem is a herbal, OTC option that differs from hormone replacement therapy (HRT) by lacking synthetic hormones. While HRT directly replaces estrogen, black cohosh extracts act via indirect pathways and may be preferred by women seeking non‑hormonal relief, though efficacy can vary between individuals.

Mensifem should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain stability.

Mensifem is taken orally, usually with water. The exact administration schedule—such as timing relative to meals—should follow the prescribing clinician’s guidance, who will consider the patient’s overall treatment plan.

Serious but rare risks include liver injury, severe allergic reactions (including anaphylaxis), and thromboembolic events. Patients should be instructed to seek immediate medical attention if they experience signs of hepatitis, unexplained jaundice, severe rash, swelling, or sudden chest pain.

Mensifem is not recommended for women who are pregnant, nursing without medical advice, have known liver disease, or are taking anticoagulant therapy without careful monitoring. Individuals with a history of severe allergic reactions to black cohosh should also avoid the product.